Russell Investments Group’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
KGAMU
6CM
WPM
QOP
RC
Russell Investments Group's CDLX Position: Q3 2025 in Review
Russell Investments Group sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 185 shares — an estimated $3.04K sold.
Russell Investments Group first reported a position in CDLX in Q1 2018 and held it in 28 quarters. The position peaked at $10.1M in Q4 2020. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.
- Russell Investments Group reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
- Russell Investments Group sold 185 Cardlytics shares in Q3 2025, an estimated $3.04K.
- Russell Investments Group first reported a position in Cardlytics in Q1 2018 and held it in 28 quarters.
- Russell Investments Group's Cardlytics position peaked at $10.1M in Q4 2020.
- 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.
Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.